Stephen Bishop
Chief Tech/Sci/R&D Officer presso ConvaTec, Inc.
Profilo
Stephen Bishop is currently working as the Vice President-Research & Development at ConvaTec, Inc. since 1990.
He is also a Member of the Society of Biology.
Previously, he worked as a Team Leader-Research & Development at Unipath Ltd.
Mr. Bishop completed his undergraduate degree from The University of Southampton.
Posizioni attive di Stephen Bishop
Società | Posizione | Inizio |
---|---|---|
ConvaTec, Inc.
ConvaTec, Inc. Medical SpecialtiesHealth Technology ConvaTec, Inc. engages in the manufacture of medical products and technologies focused on therapies for the management of chronic conditions. It specializes in the wound care, ostomy care, continence and critical care, and infusion devices. The company was founded in 1978 and is headquartered in Bridgewater, NJ. | Chief Tech/Sci/R&D Officer | 01/01/1990 |
Society of Biology | Corporate Officer/Principal | - |
Precedenti posizioni note di Stephen Bishop
Società | Posizione | Fine |
---|---|---|
Unipath Ltd.
Unipath Ltd. Pharmaceuticals: MajorHealth Technology Part of Abbott Laboratories, Unipath Ltd. is a British company that manufactures female healthcare products. The private company is based in Bedford, UK. The company was founded in 1946 by Paul James Davis. Unipath was acquired by Alere, Inc. from Unilever NV on December 20, 2001 for $146.54 million. | Chief Tech/Sci/R&D Officer | - |
Formazione di Stephen Bishop
The University of Southampton | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 3 |
---|---|
Unipath Ltd.
Unipath Ltd. Pharmaceuticals: MajorHealth Technology Part of Abbott Laboratories, Unipath Ltd. is a British company that manufactures female healthcare products. The private company is based in Bedford, UK. The company was founded in 1946 by Paul James Davis. Unipath was acquired by Alere, Inc. from Unilever NV on December 20, 2001 for $146.54 million. | Health Technology |
ConvaTec, Inc.
ConvaTec, Inc. Medical SpecialtiesHealth Technology ConvaTec, Inc. engages in the manufacture of medical products and technologies focused on therapies for the management of chronic conditions. It specializes in the wound care, ostomy care, continence and critical care, and infusion devices. The company was founded in 1978 and is headquartered in Bridgewater, NJ. | Health Technology |
Society of Biology |
- Borsa valori
- Insiders
- Stephen Bishop